Rome-based neurorehabilitation research hospital specializing in brain stimulation, assistive robotics, spinal cord repair, and disorders of consciousness.
Fondazione Santa Lucia is a leading Italian neurorehabilitation research hospital based in Rome, specializing in brain injury recovery, spinal cord injury treatment, and neurodegenerative disease research. They bring deep clinical neuroscience expertise to EU projects, particularly in assistive robotics for rehabilitation, brain stimulation therapies, and disorders of consciousness. Their work bridges clinical patient care with advanced technology — from exoskeletons and bath robots to digital brain twins — making them a translational partner that connects lab research to bedside application. More recently, they have expanded into muscle regeneration biology and computational brain modeling.
Core contributor across PD_manager (Parkinson's), I-SUPPORT (bath robots), RADIO (assisted living robots), HANK (exoskeletons for brain/spinal injury), and CogIMon (cognitive motion interaction).
NISCI tested anti-Nogo-A antibodies for spinal cord regeneration; HANK developed exoskeletons specifically for spinal cord injury rehabilitation.
Neurotwin (their largest project at EUR 867K) builds digital twins for brain stimulation; DoCMA applies brain stimulation to disorders of consciousness.
DoCMA focused on diagnosis, prognosis, and evidence-based care management for patients with disorders of consciousness.
RENOIR (2020-2025) investigates muscle cell identity, innate immunity, and the microenvironment controlling regeneration — a departure from their neuro focus.
BrainHack brought together arts, sciences, and neural computer interfaces through collaborative hackathons and co-creation events.
In 2015-2018, Fondazione Santa Lucia focused heavily on assistive robotics and physical rehabilitation — exoskeletons, bath robots, Parkinson's management platforms, and spinal cord repair through antibody therapy. From 2018 onward, their work shifted toward computational neuroscience and biological mechanisms: digital brain twins for targeted stimulation (Neurotwin), disorders of consciousness diagnostics (DoCMA), and fundamental muscle regeneration biology (RENOIR). This evolution shows a move from hardware-assisted rehabilitation toward understanding and digitally modeling the brain and body's own repair processes.
They are moving toward computational and biological approaches to neural repair — expect future projects in digital brain models, personalized brain stimulation, and regenerative medicine rather than physical robotics.
Fondazione Santa Lucia operates exclusively as a consortium partner — they have never coordinated an H2020 project, which suggests they contribute specialized clinical and neuroscience expertise rather than leading project management. With 88 unique partners across 20 countries, they are well-networked and comfortable in large international consortia. Their consistent participant role and broad partner base indicate they are a sought-after specialist that teams recruit for clinical validation, patient access, and neuroscience know-how.
They have collaborated with 88 distinct partners across 20 countries, indicating a broad European network. Their projects span robotics labs, universities, clinical centers, and SMEs — a diverse partner ecosystem reflecting their position at the intersection of clinical care and technology research.
Fondazione Santa Lucia combines a working clinical hospital with a research institute, giving them direct access to patient populations for trials — something most pure research labs cannot offer. Their dual expertise in both physical rehabilitation technologies (robots, exoskeletons) and computational neuroscience (brain stimulation, digital twins) makes them unusually versatile. For consortium builders, they offer the rare combination of clinical credibility, patient recruitment capability, and deep neuroscience research in a single partner.
